Nathalie MAUBON est née le 24 juillet 1973. Nathalie MAUBON est président de l'entreprise Hcs Pharma qui a été créée en 2014. Le chiffre d'affaires de la société n'est pas communiqué.
With 15 years of experience in the pharmaceutical research (public research, pharmaceutical industry and biotechnology company), I am a specialist in the development and automation of robust models for high-throughput screening (HCS , HTS , ADMET). I moved several positions managing projects to general direction, via managing teams and services.
Today I decided to combine the expertise of researchers from the public on the mechanism of a disease, with the researchers from industry in automation and high throughput screening, by creating HCS Pharma (http://www.hcs-pharma.com).
Molecular and cell biology : cell imaging in high throuhput (High Content Screening or HCS) , transactivation of Cos-7 cells, FRET , TR- FRET, alpha -Screen in High Speed (High Throughput Screening or HTS)
Metabolism : ADMET vitro and animal pharmacokinetic Robotics programming and use of platforms such Caliper (I- Link) , Beckman ( SAMI EX) and robot culture CompacT from TAP.